Arrows indicate additions of reagent 1 (R1) andreagent 2 (A2). we added an to aliquot of 100% saturated ice-cold (NH4)2S04 solution to yield 33% saturation of (NH4)2S04 in the test sample.
After standing on ice for 1 h, the sample was centrifuged at 4#{176}C and 1 180g for 30 mm. We carefully decanted the supernate, dissolved the precipitate in 0.5 mL of isotonic saline, and dialyzed both fractions at room temperature for 8 h against three changes of 4 L of 1120. The pH of the water was kept alkaline by adding 5 mL of 50 mmol/L barbital buffer, pH 8.6. Both fractions were again centrifuged at 1 180g for 10 mm to remove any precipitate and then were subjected to isoelectric focusing on precast polyacrylamide gels (T 5%, C = 3%) at a pH range of 3.5-9.5 (Pharmacia, Uppsala, Sweden). Total protein, immunoglobulins, and phosphate (added to give -1 mmol/L) were determined in both fractions. At the end of isoelectric focusing, we cut two 5-mmwide gel strips, one from each side of the sample lanes, and divided each strip into 5-mm-square pieces. Each piece was placed in a glass tube and eluted overnight at 4#{176}C with 1 mL of H20; the resulting pH was then measured at room temperature.
Total protein determination.
Total (Fig. 1C) . In some cases, a moderately high initial absorbance was followed by a gradual, but not marked, increase in absorbance (Fig. 1B) . In a few instances, the addition of R1 produced a very high initial absorbance, followed by a gradual drop in absorbance; in these cases, the increase in absorbance produced by the addition of R2 was often less than the maximum absorbance during the first phase (Fig. 1D) . The decrease in the absor- showed no interferences in phosphate measurements. Method I, however, produced spuriously increased phosphate results in 10 samples from multiple myeloma patients.
Thus, omitting NaC1 from R1 in method II and replacing the old detergent with a new nonionic detergent improved the performance of the ammonium molybdate-UV phosphate kit with respect to the multiple myeloma patients.
To investigate the role of NaCI concentration in the mechanism of interference, we determined plasma phosphate in samples of multiple myeloma patients in the presence of increasing concentrations of NaCI in R1 (Fig. 3) 
